Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis

Mar 23, 2024

- Mar 22, 2025

0.75

Claim your AMA PRA Category 1 Credit

This course is available for logged in users only. Please login or register to take the course.

Des experts internationaux évaluent de nouvelles données sur l’inhibition de l’aldostérone...

Integrating Next-Generation Acid Suppression into Practical Algorithms for Gastroenterolog...

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians